Celex Oncology Innovations Limited LONDON


Celex Oncology Innovations Limited is a private limited company registered at 101 New Cavendish Street, 1St Floor South, London W1W 6XH. Incorporated on 2017-11-28, this 6-year-old company is run by 3 directors.
Director Carsten F., appointed on 21 July 2019. Director Laurence C., appointed on 28 November 2017. Director Mustafa D., appointed on 28 November 2017.
The company is officially classified as "manufacture of basic pharmaceutical products" (SIC: 21100).
The last confirmation statement was sent on 2022-12-04 and the date for the subsequent filing is 2023-12-18. Additionally, the accounts were filed on 31 December 2021 and the next filing should be sent on 31 December 2023.

Celex Oncology Innovations Limited Address / Contact

Office Address 101 New Cavendish Street
Office Address2 1st Floor South
Town London
Post code W1W 6XH
Country of origin United Kingdom

Company Information / Profile

Registration Number 11085607
Date of Incorporation Tue, 28th Nov 2017
Industry Manufacture of basic pharmaceutical products
End of financial Year 31st December
Company age 7 years old
Account next due date Sun, 31st Dec 2023 (127 days after)
Account last made up date Fri, 31st Dec 2021
Next confirmation statement due date Mon, 18th Dec 2023 (2023-12-18)
Last confirmation statement dated Sun, 4th Dec 2022

Company staff

Carsten F.

Position: Director

Appointed: 21 July 2019

Laurence C.

Position: Director

Appointed: 28 November 2017

Mustafa D.

Position: Director

Appointed: 28 November 2017

Ajmal R.

Position: Director

Appointed: 01 July 2020

Resigned: 08 November 2021

Brian M.

Position: Director

Appointed: 25 September 2019

Resigned: 08 June 2020

Vasileios X.

Position: Director

Appointed: 25 September 2019

Resigned: 08 June 2020

People with significant control

The register of PSCs who own or have control over the company includes 3 names. As we found, there is Mustafa D. The abovementioned PSC has 50,01-75% voting rights and has 50,01-75% shares. The second entity in the persons with significant control register is Vasileios X. This PSC has significiant influence or control over the company,. Moving on, there is Laurence C., who also fulfils the Companies House requirements to be listed as a PSC. This PSC owns 25-50% shares and has 25-50% voting rights.

Mustafa D.

Notified on 28 November 2017
Nature of control: 50,01-75% shares
50,01-75% voting rights
right to appoint and remove directors

Vasileios X.

Notified on 25 September 2019
Ceased on 8 June 2020
Nature of control: significiant influence or control

Laurence C.

Notified on 28 November 2017
Ceased on 25 September 2019
Nature of control: 25-50% voting rights
25-50% shares

Annual reports financial information

Profit & Loss
Accounts Information Date 2018-12-31
Balance Sheet
Cash Bank On Hand2
Net Assets Liabilities2
Other
Number Shares Allotted2
Par Value Share1

Company filings

Filing category
Accounts Address Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
Confirmation statement with updates 2023-12-04
filed on: 2nd, January 2024
Free Download (4 pages)

Company search